During the past decade, WellSpan Health conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WellSpan Health" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "WellSpan Health" with 3 trials sponsored, "Biophytis" with 1 trials sponsored, "Major Extremity Trauma Research Consortium" with 1 trials sponsored and "Profound Medical Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WellSpan Health" #1 collaborator was "United States Department of Defense" with 1 trials as a collaborator and "Wellflix, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "WellSpan Health" are "Bradycardia" (2 trials), "Heart Failure" (2 trials), "Stroke" (2 trials), "Anterior Cruciate Ligament Injuries" (1 trials) and "Anterior Cruciate Ligament Rupture" (1 trials). Many other conditions were trialed in "WellSpan Health" in a lesser frequency.

Most popular intervention types in "WellSpan Health" are "Device" (8 trials), "Drug" (3 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amulet Left Atrial Appendage Occluder" (1 trials), "Aveir VR Leadless Pacemaker System" (1 trials), "BIO101" (1 trials), "Danger Signs of Heart Failure Videos" (1 trials) and "Implantation of a QuickFlex® μ Model 1258T LV Lead" (1 trials). Other intervention names were less common.

The vast majority of trials in "WellSpan Health" are 12 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "WellSpan Health". 1 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in WellSpan Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in WellSpan Health, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".